Your browser doesn't support javascript.
loading
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
Huang, Yu-Hua; Zhang, Chris Zhi-Yi; Huang, Qun-Sheng; Yeong, Joe; Wang, Fang; Yang, Xia; He, Yang-Fan; Zhang, Xiao-Long; Zhang, Hua; Chen, Shi-Lu; Zheng, Yin-Li; Deng, Ru; Lin, Cen-Shan; Yang, Ming-Ming; Li, Yan; Jiang, Chen; Kin-Wah Lee, Terence; Ma, Stephanie; Zeng, Mu-Sheng; Yun, Jing-Ping.
Afiliação
  • Huang YH; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Zhang CZ; MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, 510632, China.
  • Huang QS; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Yeong J; Department of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore; Institute of Molecular Cell Biology (IMCB), Agency of Science, Technology and Research (A∗STAR), Singapore, 169856, Singapore; Singapore Immunology Network, Agency of Science (SIgN), Technology and Re
  • Wang F; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Molecular Diagnosis, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China.
  • Yang X; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • He YF; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Zhang XL; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China.
  • Zhang H; Center for Infection and Immunity Study, School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Chen SL; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Zheng YL; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Deng R; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Lin CS; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Yang MM; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Li Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Jiang C; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Kin-Wah Lee T; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong.
  • Ma S; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
  • Zeng MS; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China.
  • Yun JP; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China. Electronic address:
J Hepatol ; 74(4): 838-849, 2021 04.
Article em En | MEDLINE | ID: mdl-33212090
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Herpesvirus Humano 4 / Infecções por Vírus Epstein-Barr / Microambiente Tumoral / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Herpesvirus Humano 4 / Infecções por Vírus Epstein-Barr / Microambiente Tumoral / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China